United States · FDA National Drug Code directory
Liothyronine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-114_c2af2408-91ba-b0c3-349f-20ca285e0fc9
- Product NDC
- 70377-114
- Form
- TABLET
- Composition / generic term
- Liothyronine sodium
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240212
- Source listing expiry
- 20261231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 5 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (70377-114-11) · 70377-114-11
- 100 TABLET in 1 BOTTLE (70377-114-12) · 70377-114-12
- 1000 TABLET in 1 BOTTLE (70377-114-13) · 70377-114-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →